Is there any role for bisphosphonate or alternative bone-modifying agents use in SMM in the absence of other indications for its use?
Answer from: Medical Oncologist at Academic Institution
The short answer is no, unless the patient has an indication like osteoporosis. Bisphosphonates have been evaluated in smoldering multiple myeloma in studies performed over 10 years ago. Treatment with pamidronate (D’Arena et al., 2011) or zoledronic acid (Musto et al., 2008) did not affect th...
Comments
Medical Oncologist at Valley Med Onc I tend to use Zoledronic acid once or twice a year...
I tend to use Zoledronic acid once or twice a year...